NCT07322263
- Conditions
- BCG-Refractory Bladder Cancer, BCG-Unresponsive Bladder Cancer, Bladder Cancer, +25 more
- Locations
-
- University of Iowa Iowa City, Iowa, United States
Clinical trial condition
Micropapillary Variant Urothelial Carcinoma (Favorable Subtype)
Explore clinical trials studying Micropapillary Variant Urothelial Carcinoma (Favorable Subtype). Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study